Senseonics Initiates First-In-Human Study Of Freedom
Benzinga Newsdesk 3 weeks ago
BiotechGeneralNews
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
First clinical evaluation of investigational, transmitter-free one-year CGM marks an important milestone on Senseonics’ innovation roadmap, with potential launch in 2028Built on the proven sensing technology behind
First clinical evaluation of investigational, transmitter-free one-year CGM marks an important milestone on Senseonics’ innovation roadmap, with potential launch in 2028
Built on the proven sensing technology behind Eversense 365 and supported by encouraging preclinical data to reduce development risk
